These results suggest that the increased CAMP levels were due to adenosine receptor activation by the extracellular adenosine accumulated on nAChR activation.
Others have shown that desensitization of the nAChR by agonist is mediated, in part, by phosphorylation.
Since we found that nicotinic cholinergic agonists also cause adenosine accumulation with concomitant CAMP increases, we determined whether the accumulated adenosine has a role in desensitization. We found that the adenosine receptor antagonist, BW 143411, significantly inhibited carbachol-induced nAChR desensitization, indicating that extracellular adenosine is involved in nAChR desensitization.
Our data suggest that nAChR function is regulated via a feedback mechanism mediated by adenosine released from muscle on activation of the nAChR.
The nicotinic ACh receptor (nAChR) is a ligand-operated ion channel whose activation results in membrane depolarization (Stroud et al., 1990) . Similar to other ligand-gated channels, nAChRs desensitize in the continued presence of agonist (Katz and Thesleff, 1957) . nAChR function can be modulated by the activation of second messenger-dependent protein kinases. CAMP-dependent protein kinase (PKA) phosphorylates the nAChR (Huganir and Greengard, 1983) , resulting in an increased rate of desensitization of purified nAChR reconstituted into phospholipid vesicles (Huganir et al., 1986) . In addition, calcium/phospholipid-dependent protein kinase C (Safran et al., 1987; Smith et al., 1989) and tyrosine-specific protein kinase (Huganir et al., 1984; Hopfield et al., 1988) phosphorylate purified nAChR. Tyrosine phosphorylation of the purified receptor also results in an increased rate of desensitization (Hopfield et al., 1988) . Agents that raise intracellular CAMP and activate PKA have been shown to increase the rate of desensitization of the nAChR in intact skeletal muscle cells (Albuquerque, 1986; Middleton et al., 1986 Middleton et al., , 1988 Grassi et al., 1987) . Activators of PKC also appear to increase the rate of nAChR desensitization (Eusebi et al., 1985 (Eusebi et al., , 1987 Caratsch et al., 1989) . It is not clear, however, how intracellular second messenger levels required for activation of these protein kinases are increased concomitant with nAChR activation, since nAChRs are not directly coupled to second messenger generation. Two putative regulators of nAChR phosphorylation and function have been identified using cultured cells: (1) calcitonin gene-related peptide, which is coreleased with ACh at the neuromuscular junction (Fontaine et al., 1986; New and Mudge, 1986) increases nAChR phosphorylation and increases the rate of desensitization of the nAChR (Laufer and Changeaux, 1987; Mulle et al., 1988) , and (2) thymopoietin also increases the rate of nAChR desensitization (Revah et al., 1987) .
In many cell types, adenosine is an autocrine modulator of several signal transduction systems (Silinksy and Hubbard, 1973; Born et al., 1975; Wiklund et al., 1985; Gustafsson and Wiklund, 1986; Ribeiro and Sebastiao, 1987; Fowler, 1988; Fredholm and Dunwiddie, 1988; Lohse et al., 1988) . Adenosine is known to be released from contracting muscle (Rubio et al., 1969; Bockman et al., 1975; Bockman and McKenzie, 1983; Thompson et al., 1986; Karim et al., 1988; Poucher et al., 1990) . In addition, ATP is coreleased with ACh from motor nerve terminals into the synaptic cleft (Silinsky and Hubbard, 1973; Wagner et al., 1978; Potter and White, 1980; Keller and Zimmerman, 1983) where enzymes rapidly degrade it to adenosine (Pearson, 1985; Kreutzberg et al., 1986) . It is possible, therefore, that after nerve stimulation and muscle activation, increased extracellular adenosine modulates nAChR activity by acting on adenosine A, receptors to increase CAMP. In this report, we present evidence that adenosine is released from cultured muscle cells on nAChR activation and regulates nAChR desensitization. Tissue culture. Primary cultures of neonatal rat hind limb muscle were prepared as previously described (Rubin, 1985) . Briefly, l-d-old
The Journal of Neuroscience. Sprague-Dawley rats (Bantin and Kingman, Fremont, CA) were killed by cervical dislocation and the hind limbs removed. Following removal of the skin, the muscle was cut and subjected to 2 x 20 min trypsin digestions (0.05% trypsin; Difco, Detroit, MI) at 37°C. Individual muscle cells were isolated by trituration.
To remove the nonmuscle cells (mainly fibroblasts), cells were plated for 1 hr, after which time the less adherent muscle cells were collected and 2 x lo6 cells were plated onto 35 mm collagen-coated tissue culture dishes. Cells were incubated at 37°C in 10% CO, in Dulbecco's modified Eagle's medium (DMEM; GIBCO) supplemented with 20% fetal calf serum (Hyclone), 1% glutamine. 100 U/ml penicillin, and 100 &ml streptomycin. After 48 hr, musclecell fusion and formation of myotubes were initiated by replacing media with DMEM, 10% horse serum, 2% chick embryo extract (GIB-CO), 100 U/ml penicillin, and 100 r&ml streptomycin. The myotubes contracted spontaneously after 3 d in culture. There were 76.8 f 12 (n = 13) nmol of cY-bungarotoxin (cu-Bgt) binding sites per lo6 cells when cells were used on day 5-6. Fibroblast cultures were obtained from the adherent cells after differential plating. They were treated in the same manner as muscle cells.
Measurement of extracellular adenosine. Myotube cultures were incubated in 2 ml of buffer containing 130 mM NaCl, 5.4 mM KCl, 5 mM CaCl,, 0.8 mM MgCl,, 20 mM HEPES, and 24 mM glucose, pH 7.4, with or without carbachol. Extracellular media were collected at the indicated times and centrifuged to remove cell debris. Ammonium acetate (2.5 M, pH 9.5) and a fixed amount of tubericidin (as an internal standard) were added to the media. Adenosine was adsorbed on a boronate affinity column (Affigel60 1, Bio-Rad), eluted, and incubated with chloracetaldehyde (Green, 1980) to form a fluorescent derivative. Samples were injected onto a reversed-phase high-pressure liquid chromatography column equilibrated with 1.2 mM KH,PO,, pH 5, and the adenosine derivative eluted with a O-60% methanol gradient. Fluorescence of the eluted sample was monitored at an excitation wavelength of 280 nm (Green, 1980) . The adenosine peak was identified by corn&ration with adenosine standards and by the loss of the peak after adenosine deaminase treatment.
CAMP measurement. Myotube cultures were incubated for 60 min in 1 ml of buffer (see above) containing the phosphodiesterase inhibitor ZK-62711 (ZK, 10 PM). The cells were incubated for a further 30 min in the presence and absence of appropriate drugs and the continued presence of ZK. CAMP concentrations were measured by radioimmunoassay (Koch et al., 1983; Gordon et al., 1986) . In experiments with carbachol, CAMP was acetylated to increase the sensitivity of the assay.
Wodium uptake. Myotubes were preincubated for 30 min at room temperature in 1 ml of buffer in the presence or absence of adenosine receptor antagonists. Five minutes prior to the experiment, buffer was removed and replaced with 1 ml of fresh buffer with or without 30 NM carbachol. The medium was then removed and medium containing 100 PM carbachol, 1 pCi/ml 22Na, and 1 mM ouabain was added and the cells incubated for 30 sec. Cells were then washed three times at 4°C with buffer containing 1 mM ouabain and 10 nM cu-Bgt and incubated with 0.4 N NaOH overnight. 22Na was measured on a Beckman gamma counter.
Protein determination. Protein concentration was determined by the method of Bradford (1976 1A) and dose-dependent (Fig. 1B) increase in adenosine in the extracellular media. Increases in extracellular adenosine concentration were obtained at carbachol concentrations that produce ion channel opening, cell depolarization, and contraction (Sine and Taylor, 1979; Jackson, 1988) . The nAChR antagonists Naja naja siamensis toxin (100 nM) and a-Bgt (5 nM 
Primary muscle cells have adenosine receptors coupled to CAMP generation
If adenosine has an autoctine effect on muscle cells, then adenosine receptors should be present on these cells. We found that PIA, an adenosine receptor agonist that acts at both A, and A, receptors (Daly, 1985) , produced dose-dependent increases in CAMP in the primary muscle cells, with a half-maximal response at 5 + 1 PM (Fig. 2) . PIA-stimulated CAMP production was completely inhibited by the nonselective adenosine antagonist BW 1434U (1 PM) (Fig. 2) . PIA did not induce CAMP production in cultures of nonmyocyte cells (data not shown). These data indicate that adenosine receptors, most likely A, receptors, couple to adenylyl cyclase to increase CAMP levels in muscle cells.
Activation of nAChR increases intracellular CAMP concentration
If the extracellular adenosine that accumulates following nAChR stimulation activates adenosine receptors, then CAMP levels should increase after nAChR activation. We found that carbachol caused a dose-dependent increase in CAMP levels (Fig.  3, solid circles) . This increase in CAMP levels is consistent with the CAMP levels reached after stimulation by adenosine at concentrations similar to those produced by carbachol (Fig. 1) . For example, 100 PM carbachol results in accumulation of 300 nM adenosine ( Fig. 1) . At 300 nM, adenosine causes an increase in CAMP of 86% from 3.75 pmol/mg to 7 pmol/mg. A similar increase, -9O%, in CAMP levels over basal is obtained with 100 PM carbachol (Fig. 3) . Carbachol-induced CAMP generation was inhibited by incubating the muscle cell cultures with ADA (Fig. 3, open triangles) , an enzyme that hydrolyzes adenosine to inosine. Inosine has a low affinity for the adenosine receptor (Daly, 1985) and therefore does not increase CAMP levels. An adenosine receptor antagonist, BW 1434U, also decreased carbachol-induced CAMP levels (Fig. 3, open squares) . Therefore, the increase in CAMP appears to be due to activation of adenosine receptors coupled to CAMP generation. Basal CAMP levels in muscle cells were also decreased by ADA (43 f 4%, n = 1 l), or by BW 1434U (Fig. 3) , suggesting that even under basal conditions, adenosine is released by the muscle cells and modulates cellular CAMP levels via adenosine receptors. Carbachol-induced increases in CAMP were due to nAChR activation since 5 nM cw-Bgt inhibited the CAMP increase by 76 + 6% (n = 6). Therefore, extracellular adenosine accumulation that occurs on activation of the nAChR by carbachol is sufficient to increase intracellular CAMP levels.
Adenosine modulates nAChR desensitization
To determine whether the extracellular adenosine that accumulates on nAChR activation modulates nAChR function, we measured desensitization of carbachol-induced **Na influx into cultured muscle cells. Incubation of cells with 100 PM carbachol caused a time-dependent increase in 2*Na influx (data not shown). A 5 min preincubation with 30 I.LM carbachol caused a reduction Intracellular levels of CAMP were determined after incubation of cells with carbachol alone (0) or carbachol with either 1 PM BW 1434U (0) or 1 U/ml ADA (A). Results are expressed as a percentage of CAMP produced in the absence of carbachol. CAMP levels were 7 + 1 pmol/ mg protein in the absence of carbachol and 12 + 2 pmol/mg protein in the presence of 100 PM carbachol (mean -C SEM; n = 5). *, p < 0.05; **, p i 0.01; Student's t test.
in the amount of 22Na influx on subsequent carbachol addition, reflecting agonist-induced desensitization of the nicotinic receptor (Catterall, 1975) . Carbachol-induced desensitization averaged 72 f 10% (range, 43-108%) ( Fig. 4 ; p < 0.0001, twotail paired t test). (Only experiments where desensitization exceeded 40% were included.) If nAChR-mediated adenosine accumulation contributes to this desensitization, then the adenosine receptor antagonist BW 1434U should inhibit desensitization (Clemo et al., 1987) . In all of these experiments, a significant inhibition of nicotinic receptor desensitization by BW1434U was observed; an average of 40 + 10% desensitization was obtained in the presence of BW1434U (Fig. 4 ; p < 0.0 1, two-tail paired t test; n = 9). Furthermore, the methylxanthine derivative isobutylmethylxanthine (10 PM), another adenosine receptor antagonist (Trivedi et al., 1990) , caused a similar decrease in desensitization (26 f 3% decrease; n = 2). In contrast, the A,-specific antagonist DPCPX (Bruns et al., 1987) had no effect on carbachol-induced desensitization (0 f 3% decrease in desensitization; n = 2). These results suggest that there is an adenosine-mediated component to the carbachol-induced desensitization. Taken together, the data presented here support the hypothesis that adenosine accumulates following nAChR activation and contributes to nAChR desensitization via activation of adenosine A, receptors.
Discussion
In this report, we present evidence for a novel feedback mechanism regulating nAChR function. Activation of nAChR results in an increase in extracellular adenosine concentration. This increase leads to stimulation of adenylyl cyclase via A, adenosine receptors, resulting in increased CAMP levels. We have also shown that activation-induced increases in extracellular adenosine concentration contribute to agonist-induced desensitization of the nAChR. These results suggest that activation of the nAChR modulates its own function by an adenosinemediated mechanism.
Previous studies in other laboratories have provided evidence of a role for PKA in the modulation of nAChR activity, particularly desensitization (for reviews, see Huganir and Miles, 1989; Ochoa et al., 1989) . Desensitization of the nAChR occurs in phospholipid vesicles reconstituted with purified Torpedo nAChR (Huganir et al., 1986) suggesting that desensitization can occur in the absence of other cellular components. This desensitization appears to be due to an agonist-induced conformational change in the receptor (Barrantes, 1978) . Huganir et al. (1986) also demonstrated that purified nAChR, phosphorylated by PKA, desensitized at a greater rate than nonphosphorylated receptor. Therefore, it appears that there are two components to nAChR desensitization, both of which require the presence of agonist; one is induced directly by agonist binding and a second is mediated by nAChR phosphorylation (Huganir and Greengard, 1987) .
Phosphorylation of the 6-and y-subunits of nAChR by PKA has been well documented (Souroujon et al., 1986; Miles et al., 1987; Smith et al., 1987) . Whether phosphorylation of the nAChR in intact cells results in desensitization has been the subject of some debate (Albuquerque et al., 1986; Middleton et al., 1986 Middleton et al., , 1988 Haggblad et al., 1987; Wagoner and Pallotta, 1988) . However, it appears that CAMP analogs and low concentrations of forskolin enhance nAChR desensitization via CAMP (Middleton et al., 1988 ) presumably due to PKA-dependent phosphorylation. In our study, nAChR activation leads to increased extracellular adenosine accumulation with consequent increases in CAMP levels. These increases were blocked by both nAChR and adenosine receptor antagonists. Moreover, the adenosine receptor antagonist BW1434U partially inhibited carbachol-induced desensitization of sodium influx. These data lend support to the hypothesis that agonist-induced nAChR desensitization is, at least in part, due to increased intracellular CAMP levels and PKA-dependent phosphorylation of the nAChR.
In vivo, accumulation of extracellular adenosine due to release from muscle by cholinergic stimulation of the nAChR would occur in a very restricted volume at the neuromuscular junction. In addition, adenosine is produced by degradation of ATP that is coreleased with ACh on nerve stimulation (Silinsky and Hubbard, 1973) . Therefore, the relative concentration of adenosine at the synapse would be expected to be higher than we observed in our cell culture system. Under these conditions, adenosine released from muscle by activation of the nAChR should cause even larger increases in CAMP levels and PKA activity.
In summary, our data provide evidence for a feedback mechanism in which nAChR desensitization is increased by extracellular adenosine produced by nAChR activation. The levels of extracellular adenosine increased as a function of nAChR stimulation. Adenosine, acting via an A, receptor, caused increased intracellular CAMP. These increased CAMP levels appear to contribute to ACh-mediated nAChR desensitization. The function of other ligand-gated ion channels such as the GABA, (Porter et al., 1990 ) and glutamate receptors (Greengard et al., 1991; Wang et al., 1991) is also modulated by PKA phosphorylation. Since adenosine is secreted by most cells and adenosine is produced from ATP released in synaptic vesicles, the function of other ligand-gated ion channels in addition to the nAChR may be modulated by adenosine.
